Investing

Orexigen, Advaxis Tumble into Tuesday's 52-Week Low Club

March 13, 2018: Here are four stocks trading with heavy volume among 36 equities making new 52-week lows in Tuesday’s session. On the NYSE decliners led advancers by about 3 to 2 and on the Nasdaq, decliners led advancers by about 9 to 5.

Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

Globalstar Inc. (NYSEAMERICAN: GSAT) traded down about 12.5% Tuesday and posted a new 52-week low of $0.77 after closing Monday at $0.88. The stock’s 52-week high is $2.59. Volume was about 70% above the daily average of around 3.7 million shares. The had no specific news.

Advaxis Inc. (NASDAQ: ADXS) fell about 20% Tuesday to post a new 52-week low of $1.76 after closing at $2.21 on Monday. The 52-week high is $9.55. Volume of around 3.7 million was about three times the daily average. The company said late Monday that a cancer drug test has been placed on hold following a patient’s death.

Piedmont Office Realty Trust Inc. (NYSE: PDM) dropped about 3.5% Tuesday to post a new 52-week low of $17.35. Shares closed at $17.98 on Monday and the stock’s 52-week high is $22.74. Volume was about 60% above the daily average of around 1.3 million shares. The company had no specific news.

Sponsored: Want to Retire Early? Here’s a Great First Step

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.